Effect Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Age Of Onset, Allergic Status, And Eosinophilic Phenotype

被引：0

作者：

Mathur, Sameer ^{[1
]}

Hill, Jennifer ^{[2
]}

Ambrose, Chris ^{[3
]}

Martin, Nicole ^{[4
,5
]}

Llanos-Ackert, Jean-Pierre ^{[6
]}

Martin, Neil ^{[7
,8
]}

Colice, Gene ^{[9
]}

机构：

[1] Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, Madison, WI USA

[2] San Tan Allergy & Asthma, Arizona Allergy & Immunol Res, Gilbert, AZ USA

[3] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA

[4] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biometr,Late Stage Dev, Waltham, MA USA

[5] Cytel Inc, Waltham, MA USA

[6] Amgen Inc, Global Med Affairs, Thousand Oaks, CA 91320 USA

[7] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Cambridge, England

[8] Univ Leicester, Leicester, Leics, England

[9] AstraZeneca, Biopharmaceut R&D, Resp & Immunol, Late Stage Dev, Gaithersburg, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

051

引用

页码：AB17 / AB17

页数：1